| Product Code: ETC9625368 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Next Generation Cancer Diagnostics Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Next Generation Cancer Diagnostics Market - Industry Life Cycle |
3.4 Taiwan Next Generation Cancer Diagnostics Market - Porter's Five Forces |
3.5 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F |
3.8 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F |
4 Taiwan Next Generation Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Taiwan |
4.2.2 Growing awareness and adoption of advanced diagnostic technologies |
4.2.3 Supportive government initiatives and investments in healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for new diagnostic technologies |
4.3.2 High cost associated with next generation cancer diagnostics |
4.3.3 Limited accessibility to advanced diagnostic services in certain regions of Taiwan |
5 Taiwan Next Generation Cancer Diagnostics Market Trends |
6 Taiwan Next Generation Cancer Diagnostics Market, By Types |
6.1 Taiwan Next Generation Cancer Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Next-generation Sequencing, 2021- 2031F |
6.1.4 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By qPCR & Multiplexing, 2021- 2031F |
6.1.5 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021- 2031F |
6.1.6 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Protein Microarrays, 2021- 2031F |
6.1.7 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By DNA Microarrays, 2021- 2031F |
6.2 Taiwan Next Generation Cancer Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Biomarker Development, 2021- 2031F |
6.2.3 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By CTC Analysis, 2021- 2031F |
6.2.4 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Proteomic Analysis, 2021- 2031F |
6.2.5 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Epigenetic Analysis, 2021- 2031F |
6.2.6 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Genetic Analysis, 2021- 2031F |
6.3 Taiwan Next Generation Cancer Diagnostics Market, By Cancer |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.3 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.4 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.3.6 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Taiwan Next Generation Cancer Diagnostics Market, By Function |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Therapeutic Monitoring, 2021- 2031F |
6.4.3 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.4.4 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Prognostics, 2021- 2031F |
6.4.5 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Cancer Screening, 2021- 2031F |
6.4.6 Taiwan Next Generation Cancer Diagnostics Market Revenues & Volume, By Risk Analysis, 2021- 2031F |
7 Taiwan Next Generation Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Taiwan Next Generation Cancer Diagnostics Market Export to Major Countries |
7.2 Taiwan Next Generation Cancer Diagnostics Market Imports from Major Countries |
8 Taiwan Next Generation Cancer Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of next generation cancer diagnostics technologies in Taiwan |
8.2 Rate of increase in research and development investment in cancer diagnostics |
8.3 Number of partnerships and collaborations between diagnostic companies and healthcare providers in Taiwan |
9 Taiwan Next Generation Cancer Diagnostics Market - Opportunity Assessment |
9.1 Taiwan Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Taiwan Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F |
9.4 Taiwan Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F |
10 Taiwan Next Generation Cancer Diagnostics Market - Competitive Landscape |
10.1 Taiwan Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here